Harvard Bioscience 10K Form

Sell

17

HBIO
Harvard Bioscience

Last Price:

$0.33

Seasonality Move:

1.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07	10Q	HBIO/Harvard Bioscience Quarterly
2023-11-07	10Q	HBIO/Harvard Bioscience Quarterly
2023-08-08	10Q	HBIO/Harvard Bioscience Quarterly
2023-04-26	10Q	HBIO/Harvard Bioscience Quarterly
2022-11-09	10Q	HBIO/Harvard Bioscience Quarterly
2022-08-04	10Q	HBIO/Harvard Bioscience Quarterly

Receive HBIO News And Ratings

See the #1 stock for the next 7 days that we like better than HBIO

HBIO Financial Statistics

Sales & Book Value

Annual Sales:	$94.1M
Cash Flow:	$2.3M
Price / Cash Flow:	185.32
Annual Sales:	$0.34
Price / Book:	1

Profitability

EPS (TTM):	-1.32000
Net Income (TTM):	$-58.1M
Gross Margin:	$54.8M
Return on Equity:	-103.83%
Return on Assets:	-48.4%

Harvard Bioscience Earnings Forecast

Key Harvard Bioscience Financial Ratios

The Gross Profit Margin over the past 27 years for HBIO is 58.18%.
The Selling, General & Administrative Expenses for HBIO have been equal to 46.43% of Gross Profit Margin.
The Research & Development expenses have been 11.05% of Revenue.
The Net Earning history of HBIO is -13.18% of Total Revenues.
Per Share Earnings over the last 27 years have been positive in 13 years.

Harvard Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Life Sciences Tools & Services
Sector:	Health Care
Current Symbol:	HBIO
CUSIP:	416906
Website:	harvardbioscience.com

Debt

Debt-to-Equity Ratio:	2.42
Current Ratio:	0.81
Quick Ratio:	0.34

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	5.61

HBIO Technical Analysis vs Fundamental Analysis

Sell

17

Harvard Bioscience (HBIO) is a Sell

Is Harvard Bioscience a Buy or a Sell?

Harvard Bioscience stock is rated a Sell

The current Harvard Bioscience [HBIO] share price is $0.34. The Score for HBIO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.